CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer

CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer

Objective: Precision immunotherapy in non-small cell lung cancer (NSCLC) have been the focus of tumor immunity research. The aim of this study is to identify novel candidate biomarkers predicting the response to immunotherapy in NSCLC. Methods: GSE126044 was obtained from Gene Expression Omnibus (GE...

Full description

Bibliographic Details
Main Authors:	Xiaoguang Qi PhD, Chunyan Qi MS, Tao Wu BS, Yi Hu PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-11-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/1533033820970663

Similar Items

The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma
by: Yongying Zhou, et al.
Published: (2021-04-01)

Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non–Small Cell Lung Cancer from the PACIFIC Study
by: Mario Ouwens, PhD, et al.
Published: (2021-01-01)

Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis
by: Qi Liu PhD, et al.
Published: (2021-06-01)

Screening and Identification of Key Genes for Clinical Benefit of Immunotherapy on Lung Adenocarcinoma Based on TCGA Database
by: QI Xiaoguang, et al.
Published: (2020-11-01)

Combination of Fas ligand and GM-CSF in immunotherapy of lung cancer
by: Ming-Yi Ho, et al.
Published: (2004)

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
by: Takuma Imakita, et al.
Published: (2017-01-01)

Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey
by: Hiroki Hata MS, et al.
Published: (2020-12-01)

Characteristics of Candidates for Allergen Immunotherapy
by: Giorgio Ciprandi M.D., et al.
Published: (2013-09-01)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
by: Thijs W. Hoffman, MD, et al.
Published: (2020-06-01)

Factors Influencing Functional Exercise Capacity After Lung Resection for Non–Small Cell Lung Cancer
by: Masato Oikawa MSc, et al.
Published: (2020-06-01)

FasL, GM-CSF and IL-27 for Immunotherapy of Lung cancer
by: Ming-Yi Ho, et al.
Published: (2008)

Astragalus Polysaccharide Injection (PG2) Normalizes the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Lung Cancer Receiving Immunotherapy
by: Shih Ming Tsao PhD, MD, et al.
Published: (2021-02-01)

Current Status of Immunotherapy for Lung Cancer and Future Perspectives
by: Ho Cheol Kim, M.D., et al.
Published: (2020-01-01)

Predictive molecular markers in the era of immunotherapy
by: Teddy S. Nagaria, MD, PhD, et al.
Published: (2020-09-01)

Role of the immunosuppressive microenvironment in immunotherapy
by: Garth W. Tormoen, MD, PhD, et al.
Published: (2018-10-01)

Multiscale Mask R-CNN–Based Lung Tumor Detection Using PET Imaging
by: Rui Zhang PhD, et al.
Published: (2019-07-01)

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer
by: Jia-Xin Li MB, et al.
Published: (2019-12-01)

Research Progress of Biomarkers for Immunotherapy on Non-small Cell Lung Cancer
by: JIANG Meilin, et al.
Published: (2018-10-01)

CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
by: Oskar Hansson, et al.
Published: (2019-05-01)

Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma
by: Xiaoguang Qi, et al.
Published: (2020-06-01)

COMP: A Potential Early Biomarker of RAS After Lung Transplantation
by: Mirza Novo, MD, et al.
Published: (2021-08-01)

CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
by: Sophia Fotiou Magkouta, et al.
Published: (2021-05-01)

The Development of the Korean Lung Cancer Registry (KALC-R)
by: Young-Chul Kim, M.D., Ph.D., et al.
Published: (2019-04-01)

Why does Leigh syndrome respond to immunotherapy?
by: Josef Finsterer, MD, PhD, et al.
Published: (2017-06-01)

Automatic Segmentation of the Gross Target Volume in Non-Small Cell Lung Cancer Using a Modified Version of ResNet
by: Fuli Zhang PhD, et al.
Published: (2020-08-01)

CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
by: Yuzhen Wei, et al.
Published: (2018-01-01)

Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease
by: Ha Seon-Ah, et al.
Published: (2007-06-01)

UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis
by: Ruibing Li, et al.
Published: (2020-08-01)

Exploring optimal sequencing of radiation and immunotherapy combinations
by: Andrew J. Gunderson, PhD, et al.
Published: (2018-10-01)

Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy
by: Daniel R. Owen, BS, et al.
Published: (2021-05-01)

Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
by: Ricardo Brianezi Tiraboschi, MD, PhD, et al.
Published: (2021-04-01)

Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients
by: Tingting Liu PhD, et al.
Published: (2021-06-01)

Biomarker Testing for People With Advanced Lung Cancer in England
by: Jana B. Adizie, MbChB., MRCP, MD, et al.
Published: (2021-06-01)

Multiplexed Serum Biomarkers for the Detection of Lung Cancer
by: Shenglin Ma, MD, et al.
Published: (2016-09-01)

Combined Biomarker and Computed Tomography Screening Strategies for Lung Cancer
by: Chung Yin Kong PhD, et al.
Published: (2016-07-01)

Identification of Drug-resistance Core Genes and Drug Targets in Lung Adenocarcinoma Patients Harboring ALK Fusion Gene
by: QI Chunyan, et al.
Published: (2021-05-01)

Immunotherapy for small-cell lung cancer
by: A. Ye. Kuzminov, et al.
Published: (2019-06-01)

Exerts Anticancer Effect on Non–Small Cell Lung Cancer by Inhibiting Hedgehog Signaling via Suppression of TCTN3
by: Eunbi Jo MS, et al.
Published: (2020-05-01)

Immunotherapy Frontiers in Hematology
by: Simon Hallam, MA, PhD, MRCP, FRCPath
Published: (2017-12-01)

Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
by: Suraj Radhamani, Ph.D, et al.
Published: (2017-07-01)